Last reviewed · How we verify

NCT07122115

Mindfulness-Based Childbirth Education for Pregnant Women With Distress

Completed NA Last updated 14 August 2025
What this trial tests

NA trial testing Mindfulness-Based Childbirth and Parenting Education in PRENATAL DISTRESS in 31 participants. Completed in 31 May 2023.

Timeline
1 November 2022
Primary endpoint
30 April 2023
31 May 2023

Quick facts

Lead sponsorKayseri Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment31
Start date1 November 2022
Primary completion30 April 2023
Estimated completion31 May 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kayseri Training and Research Hospital

Who can join

Adults 18 to 35, female only, with PRENATAL DISTRESS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aimed to evaluate the effects of a mindfulness-based childbirth and parenting education program on pregnant women experiencing prenatal distress. A total of 31 participants were randomly assigned to either an intervention group, which received an 8-week mindfulness-based education, or a control group, which received standard prenatal care. The study assessed outcomes such as pregnancy-related stress, fear of childbirth, conscious awareness, maternal attachment, and postpartum adaptation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kayseri Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07122115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing